Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;32(6):e254-62.
doi: 10.1097/INF.0b013e3182814b30.

Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children

Affiliations

Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children

Steve Innes et al. Pediatr Infect Dis J. 2013 Jun.

Abstract

Background: The prevalence of potentially stigmatizing lipoatrophy in children receiving antiretroviral therapy in Southern Africa is high, affecting around a third of children. Early diagnosis of lipoatrophy is essential for effective intervention to arrest progression.

Methods: Prepubertal children receiving antiretroviral therapy were recruited from a hospital-based family HIV clinic in Cape Town and followed up prospectively. Lipoatrophy was identified and graded by consensus between 2 HIV pediatricians. A dietician performed anthropometric measurements of trunk and limb fat. Anthropometric measurements in children with and without lipoatrophy were compared using multivariable linear regression adjusting for age and gender. The most discerning anthropometric indicators of lipoatrophy underwent receiver operating characteristic curve analysis. The precision of anthropometric measurements performed by an inexperienced healthcare worker was compared with that of a research dietician.

Results: Of 100 recruits, 36 had lipoatrophy at baseline and a further 9 developed lipoatrophy by 15-month follow-up. Annual incidence of lipoatrophy was 12% (confidence interval [CI]: 5-20%) per person-year of follow-up. A biceps skin-fold thickness <5 mm at baseline had a sensitivity of 89% (CI: 67-100%) and a specificity of 60% (CI: 46-75%) for predicting development of lipoatrophy by 15-month follow-up. Negative and positive predictive values were 97% (CI: 91-100%) and 32% (CI: 14-50%).

Conclusion: Biceps skin-fold thickness <5 mm in prepubertal children exposed to thymidine analogue-based antiretroviral therapy may be a useful screening tool to identify children who are likely to develop lipoatrophy. The variation in precision of measurements performed by an inexperienced healthcare worker only marginally impacted performance.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflict of interest to declare.

The content of this publication does not necessarily reflect the views or policies of NIAID, nor does mention of trade names, commercial projects, or organizations imply endorsement by the US Government.

Figures

Figure 1
Figure 1
Lipoatrophy grading scores at baseline and at follow-up
Figure 2
Figure 2
Figure 2A: ROC curves of biceps SFT (solid line), triceps SFT (dashed line), and torso-to-arm SFT ratio (dotted line) to detect prevalent lipoatrophy at baseline, n = 97. The horizontal light grey shape corresponds to the pAUC region. The pAUC of biceps SFT with 95% confidence interval is printed in the middle of the plot. The best threshold of 4.8mm with corresponding specificity (60.7%) and sensitivity (88.9%) for biceps SFT is also located in the plot. ROC = Receiver Operating Characteristic curve; SFT = skin-fold thickness; pAUC = partial area-under-the-curve for sensitivity between 80% and 100%. Figure 2B: ROC curves of biceps SFT (solid line), triceps SFT (dashed line), and torso-to-arm SFT ratio (dotted line) to predict which children will go on to develop new lipoatrophy by 15 month follow-up, n = 58. The horizontal light grey shape corresponds to the pAUC region. The pAUC of biceps SFT with 95% confidence interval is printed in the middle of the plot. The best threshold of 5mm with corresponding specificity (64.6%) and sensitivity (88.9%) for biceps SFT is also located in the plot. ROC = Receiver Operating Characteristic curve; SFT = skin-fold thickness; pAUC = partial area-under-the-curve for sensitivity between 80% and 100%.
Figure 2
Figure 2
Figure 2A: ROC curves of biceps SFT (solid line), triceps SFT (dashed line), and torso-to-arm SFT ratio (dotted line) to detect prevalent lipoatrophy at baseline, n = 97. The horizontal light grey shape corresponds to the pAUC region. The pAUC of biceps SFT with 95% confidence interval is printed in the middle of the plot. The best threshold of 4.8mm with corresponding specificity (60.7%) and sensitivity (88.9%) for biceps SFT is also located in the plot. ROC = Receiver Operating Characteristic curve; SFT = skin-fold thickness; pAUC = partial area-under-the-curve for sensitivity between 80% and 100%. Figure 2B: ROC curves of biceps SFT (solid line), triceps SFT (dashed line), and torso-to-arm SFT ratio (dotted line) to predict which children will go on to develop new lipoatrophy by 15 month follow-up, n = 58. The horizontal light grey shape corresponds to the pAUC region. The pAUC of biceps SFT with 95% confidence interval is printed in the middle of the plot. The best threshold of 5mm with corresponding specificity (64.6%) and sensitivity (88.9%) for biceps SFT is also located in the plot. ROC = Receiver Operating Characteristic curve; SFT = skin-fold thickness; pAUC = partial area-under-the-curve for sensitivity between 80% and 100%.

Similar articles

Cited by

References

    1. IeDEA Southern Africa Paediatric Group. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc. 2011;14:7. - PMC - PubMed
    1. WHO. [Accessed 15 September 2011];Forecasting antiretroviral demand. 2010 http://www.who.int/hiv/amds/forecasting/en/index4.html.
    1. South African National Department of Health. The South African Antiretroviral Treatment Guidelines. Pretoria: SANDoH; 2010.
    1. Haubrich RH, Riddler SA, DiRienzo AG, et al. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009 Jun 1;23(9):1109–1118. - PMC - PubMed
    1. Shlay JC, Sharma S, Peng G, Gibert CL, Grunfeld C. Long-term subcutaneous tissue changes among antiretroviral-naive persons initiating stavudine, zidovudine, or abacavir with lamivudine. J Acquir Immune Defic Syndr. 2008 May 1;48(1):53–62. - PubMed

Publication types

Substances